Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease
Keyword(s):
Keyword(s):
2000 ◽
Vol 61
(3)
◽
pp. 403-408
◽
Keyword(s):
Keyword(s):
2010 ◽
Vol 24
(1)
◽
pp. 91-99
◽